Faculty Information - Susumu Kanazawa

（Last updated : 2022-06-20 11:44:07）

Susumu Kanazawa
Department Kawasaki Medical School Kawasaki Medical School, Department of Radiology, Division of Diagnostic and Therapeutic Radiology,

Position Professor with Special Assignment

■ BooK

2011

Chapter 2. Radiotherapy for Oral Cancer, Oral Cancer: Causes, Diagnosis and Treatment

■ Journal

1.	2021/07	Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
2.	2021/07	New field‑in‑field with two reference points method for whole breast radiotherapy: Dosimetric analysis and radiation‑induced skin toxicities assessment.
3.	2021/06	Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer.
4.	2021/06	Investigation into the Effect of Breast Volume on Irradiation Dose Distribution in Asian Women with Breast Cancer.
5.	2021/06	Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments.
6.	2021/06	Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
7.	2021/05	Visceral Adipose Mass and Radiation Pneumonitis After Concurrent Chemoradiotherapy in Patients With Non-small-cell Lung Cancer.
8.	2021/04	A PET/CT volumetric parameter predicts prognosis of non-small cell lung cancer treated using preoperative chemoradiotherapy and surgery: A retrospective case series study.
9.	2021/04	Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.
10.	2021/02	Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
11.	2021/02	Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
12.	2021/02	Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage Ill Non-small Cell Lung Cancer.
13.	2020/12	Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer.
14.	2020/10	Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer.
15.	2020/07	Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
16.	2020/07	Survival Outcomes of Treatment With Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
17.	2019/11	Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: a comparative effectiveness study.
18.	2019/11	Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
19.	2019/11	Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis.
20.	2019/07	Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
21.	2019/02	Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
22.	2018/10	Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.
23.	2018/08	Evaluation of setup errors at the skin surface position for whole breast radiotherapy of breast cancer patients.
24.	2018/06	Is Surgery After Chemoradiotherapy Feasible in Lung Cancer Patients With Superior Vena Cava Invasion?
25.	2017/09	Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin.
26.	2017/09	Induction Chemoradiotherapy Using Docetaxel and Cisplatin With Definitive-Dose Radiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.
27.	2017/04	Outcome of Radiation Monotherapy for High-risk Patients with Stage I Esophageal Cancer.
28.	2017/02	Interfractional Seminal Vesicle Motion Relative to the Prostate Gland for Image-guided Radiotherapy for Prostate Cancer with/without Androgen Deprivation Therapy: A Retrospective Cohort Study.
29.	2016/09	The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy.
30.	2016/07	Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
31.	2016/07	Lung Stereotactic Radiotherapy for Oligometastases: Comparison of Oligo-Recurrence and Sync-Oligometastases.
32.	2015/08	Comparison of Field-in-Field Radiotherapy with Conformal Radiotherapy for Unilateral Cervical Malignant Lymphoma.
33.	2015/05	Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy.
34.	2015/04	High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
35.	2015/01	Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
36.	2014/11	A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801.
37.	2012/12	Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.
38.	2012/11	MicroRNA miR-34b/c enhances cellular radiosensitivity in malignant pleural mesothelioma.
39.	2012/04	Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
40.	2012/01	Two-piece customized mold technique for high-dose-rate brachytherapy on cancers of the buccal mucosa and lip.
41.	2011/12	Ileal perforation induced by acute radiation injury under gefitinib treatment.
42.	2011/09	T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
43.	2011	The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.
44.	2009/10	A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging.
45.	2009/03	Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome after breast-conserving therapy.
46.	2007	CT-Guided Placement of a Drainage Catheter Within a Pelvic Abscess Using a Transsacral Approach.
47.	2005/01	Diagnostic Capabilities of l-131, Tl-201, and Tc-99m-MIBI Scintigraphy for Metastatic Differentiated Thyroid Carcinoma after Total Thyroidectomy.
48.	2004/07	Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
Display 5 items
Display all(48)

■ Presentation

1.	2021/09	Phase I clinical trial of OBP-301, a novel telomerase-specific oncolytic virus, in combination with radiotherapy in esophageal cancer patients （Poster notice，General）
2.	2021/04/16	The clinical result of stereotactic body radiotherapy for non-small lung cell cancer in patients aged ≥ 80 years （Speech，General）
3.	2021/04	Sarcopenia is associated with poor prognosis after concurrent chemoradiotherapy for patients with stage III non-small cell lung cancer （Speech，General）
4.	2020/11	Clinical results of particle therapy in patients with postoperative recurrence of rectal cancer （Speech，General）
5.	2020/05	Radiation Pneumonitis after Concurrent Chemoradiotherapy with docetaxel/cisplatin for Non-small Cell Lung Cancer: Dose-volume parameters analysis （Speech，General）
6.	2019/04	Proton therapy for prostate cancer: Comparison of acute toxicity between moderate-hypo and conventional fraction （Speech，General）
7.	2018/05	Current status of proton therapy in Japan （Speech，General）
8.	2018/04	Outcomes of monotherapeutic permanent brachytherapy for Japanese localized prostate cancer （Poster notice，General）
9.	2017/11	Setup error evaluation at the position of skin surface for the whole breast radiotherapy （Speech，General）
10.	2017/05	Comparison of MRI/CT fusion and CT for prostate post-implant dosimetry using sector analysis （Speech，General）
11.	2017/05	Single institutional experience of the treatment of angiosarcoma of the scalp （Poster notice）
12.	2016/04	Clinical results of radiation therapy for localized gastric lymphoma （Poster notice）
13.	2016/04	Comparison of intraoperatively linked and loose seed in prostate brachytherapy using sector analysis （Poster notice）
14.	2015/11	A retrospective evaluation of stereotactic body radiotherapy for pulmonary oligometastases in a multicenter study （Speech，General）
15.	2015/07	Stereotactic body radiotherapy (SBRT) for pulmonary oligometastases with emphasis on the difference in oligometastatic state （Speech，General）
16.	2015/05	Clinical results of particle radiotherapy using protons or carbon ions for liver oligometastases （Speech，General）
17.	2015/05	Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state （Speech，General）
18.	2015/04	Comparison of field-in-field radiotherapy with conventional radiotherapy for unilateral cervical lymphoma （Speech，General）
19.	2015/04	Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state （Speech，General）
20.	2013/04	Interobserver variability of 3T and 1.5T MRI/CT fusion-based postimplant dosimetry of prostate brachytherapy （Speech，General）
21.	2012/05	Outcomes following permanent brachytherapy in Japanese patients with intermediate-risk prostate cancer （Speech，General）
22.	2010/09	Comparison of T2*-WI/T2-WI fusion and CT/T2-WI fusion in postimplant dosimetry of prostate brachytherapy （Speech，General）
23.	2008/09	Treatment Outcomes of Proton or Carbon Ion Radiotherrapy for Chordoma of the Skull Base （Speech，General）
Display 5 items
Display all(23)